食管切除术后复发监测
该回顾性研究纳入2007至2018年单中心225例食管癌食管切除术患者,比较影像学监测与单纯病史体格检查对复发检出及生存的影响。影像学监测组与体格检查组复发率相似,但复发后影像学监测组中位总生存期显著更长。
要点
- 影像学监测组与体格检查组复发率相似(40.6% vs 37.9%,P = .68)。
- 复发后接受额外治疗的比例两组相似(87.8% vs 72.3%,P = .468)。
- 复发患者中影像学监测组中位总生存期23个月 vs 体格检查组16个月(P = .047)。
核心结论
- 食管切除术后影像学监测与复发检出率改善无关,但与复发检出后总生存期改善相关。
- 这些数据提示早期识别食管癌复发可能具有生存获益。
- 标准化影像学监测可能对食管切除术后患者有益。
研究设计与样本
- 回顾性研究,纳入2007年至2018年间单中心所有因食管癌行食管切除术的患者。
- 共225例食管癌患者接受食管切除术,其中101例(44.9%)接受影像学监测,124例(55.1%)接受常规病史和体格检查随访。
- 排除食管切除术后3个月内发生复发的患者。
主要发现
- 共88例(39.1%)复发,中位随访12个月。
- 影像学监测组复发41/101例(40.6%),体格检查组复发47/124例(37.9%),两组复发率相似(P = .68)。
- 复发患者中,影像学监测组接受额外治疗36/41例(87.8%),体格检查组34/47例(72.3%),两组相似(P = .468)。
- 复发患者中,影像学监测组中位总生存期23个月,体格检查组16个月,差异显著(P = .047)。
临床怎么用
- 原文结论指出影像学监测与复发后总生存期改善相关,并建议标准化影像学监测可能对食管切除术后患者有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines for follow-up after esophagectomy suggest only history and physical examination (HPE). With recent advances in chemotherapy and immunotherapy for patients with recurrent esophageal cancer, we hypothesized that surveillance imaging (SI) would identify patients with cancer recurrence earlier and improve long-term survival. METHODS: A retrospective review of all patients undergoing esophagectomy for esophageal cancer at a single institution between 2007 and 2018 was conducted. Patients were categorized as recurrence detected through SI or recurrence detected through HPE alone. Patients were excluded if recurrence occurred within 3 months of esophagectomy. RESULTS: During the study period, 225 esophageal cancer patients underwent an esophagectomy. Among these, 101 (44.9%) had SI and 124 (55.1%) had routine follow-up with HPE. There were 88 recurrences (39.1%) with median follow-up of 12 months. Rate of recurrence was similar based on screening method: 41 of 101 (40.6%) by SI and 47 of 124 (37.9%) by HPE (P = .68). Among patients with recurrence, recipients of additional treatment were also similar between groups, 36 of 41 (87.8%) by SI and 34 of 47 (72.3%) by HPE (P = .468). Among those who had a recurrence, the median overall survival was significantly longer in those undergoing SI at 23 months compared with those who received HPE at 16 months (P = .047). CONCLUSIONS: SI after esophagectomy is not associated with improved detection of recurrence, but is associated with improved overall survival once recurrence is detected. These data suggest that earlier identification of esophageal cancer recurrence may have survival benefit. Standardizing SI may prove beneficial for patients after esophagectomy.
引用
- Chang C, Linden PA, Jiang B, et al. Monitoring for Recurrence After Esophagectomy. Ann Thorac Surg. 2021. PMID: 34793765. doi:10.1016/j.athoracsur.2021.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。